Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in multiple publications regarding the Food and Drug Administration’s lack of policy on clinical decision support, and how the MEDTECH Act will help software developers create new clinical decision support tools without confusion or delays.
Following is an excerpt from FierceHealthIT:
Bradley Merrill Thompson, an attorney with Epstein Becker Green who serves as general counsel for the CDS Coalition, tells FierceHealthIT in an email that the group is working to develop a policy proposal that deals with the regulatory uncertainty head on. The coalition, he says, wants to blend international standards and other consensus approaches with innovative ideas.
“We may not try to fully bake the ideas ourselves, but rather get them in decent enough shape to release them for public discussion and comment,” Thompson says. “I would love to get feedback from all the different stakeholders because the issues are complex, and there is risk of unintended consequences if it isn’t well vetted.”
Government Health IT, 2/26/2016